Renaissance Capital logo

EQRx (CM Life Sciences III) Priced, Nasdaq: EQRX

Third blank check company formed by Casdin Capital and Corvex Management targeting a life science business (completed 12/17/2021).

Industry: SPAC

First Day Return: +11.9%

Industry: SPAC

We are a newly organized blank check company incorporated in January 2021 as a Delaware corporation for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. To date our efforts have been limited to organizational activities as well as activities related to this offering. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. While we may pursue an initial business combination target in any industry, sector or geographic region, we intend to capitalize on our management team’s background and experience to identify promising opportunities in the life sciences sector.
more less

EQRx (CM Life Sciences III) (EQRX) Performance